XML 95 R35.htm IDEA: XBRL DOCUMENT v3.20.1
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2019
EARNINGS PER SHARE  
Schedule of calculation of earnings (loss) per share

The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Successor

 

 

Predecessor

 

 

Period from

 

 

Period from

 

 

 

 

 

 

 

 

October 2, 2019

 

 

January 1, 2019

 

 

 

 

 

 

 

 

through

 

 

through

 

Years Ended December 31,

 

    

December 31, 2019

  

  

October 1, 2019

    

2018

    

2017

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) available to common stockholders

 

$

(10,460)

 

 

$

(1,156,053)

 

$

45,959

 

$

487,679

Weighted average basic number of common shares outstanding

 

 

16,204

 

 

 

158,925

 

 

157,011

 

 

132,763

Basic net income (loss) per common share

 

$

(0.65)

 

 

$

(7.27)

 

$

0.29

 

$

3.67

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) available to common stockholders

 

$

(10,460)

 

 

$

(1,156,053)

 

$

45,959

 

$

487,679

Weighted average basic number of common shares outstanding

 

 

16,204

 

 

 

158,925

 

 

157,011

 

 

132,763

Common stock equivalent shares representing shares issuable upon:

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of Predecessor stock options

 

 

 —

 

 

 

Anti-dilutive

 

 

Anti-dilutive

 

 

Anti-dilutive

Exercise of Predecessor warrants

 

 

 —

 

 

 

Anti-dilutive

 

 

Anti-dilutive

 

 

Anti-dilutive

Conversion of Predecessor preferred stock

 

 

 —

 

 

 

 —

 

 

 —

 

 

Anti-dilutive

Vesting of Predecessor restricted shares

 

 

 —

 

 

 

Anti-dilutive

 

 

284

 

 

813

Exercise of Successor Series A Warrants

 

 

Anti-dilutive

 

 

 

 —

 

 

 —

 

 

 —

Exercise of Successor Series B Warrants

 

 

Anti-dilutive

 

 

 

 —

 

 

 —

 

 

 —

Exercise of Successor Series C Warrants

 

 

Anti-dilutive

 

 

 

 —

 

 

 —

 

 

 —

Weighted average diluted number of common shares outstanding

 

 

16,204

 

 

 

158,925

 

 

157,295

 

 

133,576

Diluted net income (loss) per common share

 

$

(0.65)

 

 

$

(7.27)

 

$

0.29

 

$

3.65